Lovly and coworkers have developed a melanoma-specific multiplex mutational profiling assay to detect the 43 recurrent mutations occurring in 6 genes frequently mutated in melanomas: BRAF, NRAS, KIT, GNAQ, and GNA11 [54]. The gene discussed is BRAF; the disease is melanoma.